Abstract
During the ongoing year were published results from clinical trials opening new perspectives in the treatment of chronic inflammatory and dysimmune skin diseases. If this therapeutic development still predominantly on moderate-to- severe forms of plaque psoriasis, it tends to be more diversified towards moderate-to- severe forms of other diseases heavily impacting on patients'lives such as atopic dermatitis in adulthood, and hidradenitis suppurativa. Likewise, the development of IL-17 and IL-23 biological inhibitors, but also of small molecules such as tofacitinib in psoriasis, and the achievement of dupilumab phase 2 studies in atopic dermatitis provide evidence for the high efficacy of these therapies, while adalimumab is the first drug to be approved for the treatment of hidradenitis suppurativa. On the other hand, advances in vaccinology allowed the successful development of innovative vaccine respectively against Herpes zoster and 9 serotypes of human papillomavirus. For all these interventions, prolonged real-life pharmacovigilance will be necessary to provide a more accurate picture of their respective benefit-to- risk balances.
References
Jul 22, 2014·The British Journal of Dermatology·A B KimballM Sundaram
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study
Mar 11, 2015·Nature·Tamara KoppSauzanne Khalilieh
Mar 15, 2015·The Journal of Allergy and Clinical Immunology·James G KruegerPaul Scholl
Apr 29, 2015·The New England Journal of Medicine·Himal LalUNKNOWN ZOE-50 Study Group
Apr 29, 2015·The New England Journal of Medicine·Jeffrey I Cohen
May 7, 2015·The New England Journal of Medicine·Lisa Rosenbaum
May 15, 2015·The New England Journal of Medicine·Lisa Rosenbaum
Jun 9, 2015·Lancet·Hervé BachelezUNKNOWN OPT Compare Investigators
Jun 9, 2015·Lancet·Mark Lebwohl
Jun 15, 2015·Lancet·Hervé Bachelez
Jun 15, 2015·Lancet·Christopher E M GriffithsUNKNOWN UNCOVER-2 and UNCOVER-3 investigators
Jun 21, 2015·Journal of the American Academy of Dermatology·Diamant ThaçiMarina Milutinovic
Jul 3, 2015·Lancet·Iain B McInnesUNKNOWN FUTURE 2 Study Group
Jul 15, 2015·The New England Journal of Medicine·Kenneth B GordonKristian Reich
Aug 12, 2015·Journal of the American Academy of Dermatology·Ian LandellsBruce Randazzo
Oct 1, 2015·The New England Journal of Medicine·Mark LebwohlAjay Nirula
Oct 1, 2015·The New England Journal of Medicine·Philip J MeaseUNKNOWN FUTURE 1 Study Group